BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16938584)

  • 1. Inflammatory and long-term risk markers.
    Levinson SS
    Clin Lab Med; 2006 Sep; 26(3):553-70, v. PubMed ID: 16938584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum markers of vascular inflammation in dyslipemia.
    Francisco G; Hernández C; Simó R
    Clin Chim Acta; 2006 Jul; 369(1):1-16. PubMed ID: 16469304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of inflammation in atherothrombosis: current and future strategies of medical treatment.
    Geisler T; Bhatt DL
    Med Sci Monit; 2004 Dec; 10(12):RA308-16. PubMed ID: 15567994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessment.
    Wu JT; Wu LL
    Clin Chim Acta; 2006 Apr; 366(1-2):74-80. PubMed ID: 16343470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrates and markers of inflammation].
    Broncel M
    Pol Merkur Lekarski; 2007 Jan; 22(127):58-61. PubMed ID: 17477093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans.
    Lehrke M; Millington SC; Lefterova M; Cumaranatunge RG; Szapary P; Wilensky R; Rader DJ; Lazar MA; Reilly MP
    J Am Coll Cardiol; 2007 Jan; 49(4):442-9. PubMed ID: 17258089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CRP--a marker of a pro-inflammatory state and cardiovascular risk].
    Poledne R; Valenta Z; Pit'ha J
    Vnitr Lek; 2007 Apr; 53(4):391-5. PubMed ID: 17578172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
    Anderson JL
    Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrinogen--acute phase protein as a marker of immunological process as atherosclerosis].
    Rajtari R; Kloch M; Kiec-Wilk B; Kolasińska-Kloch W
    Folia Med Cracov; 2005; 46(1-2):21-32. PubMed ID: 17037285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of premature atherosclerosis.
    Kampoli AM; Tousoulis D; Antoniades C; Siasos G; Stefanadis C
    Trends Mol Med; 2009 Jul; 15(7):323-32. PubMed ID: 19577961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [C-reactive protein: cardiovascular issues of an acute-phase protein].
    Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R
    Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part I].
    Rajtar R; Kloch M; Bober M; Kolasińska-Kloch W
    Przegl Lek; 2006; 63(9):762-6. PubMed ID: 17479866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory markers in depression.
    Dinan TG
    Curr Opin Psychiatry; 2009 Jan; 22(1):32-6. PubMed ID: 19122532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokines in cardiovascular risk prediction.
    Aukrust P; Yndestad A; Smith C; Ueland T; Gullestad L; Damås JK
    Thromb Haemost; 2007 May; 97(5):748-54. PubMed ID: 17479185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis.
    Ranjit N; Diez-Roux AV; Shea S; Cushman M; Seeman T; Jackson SA; Ni H
    Arch Intern Med; 2007 Jan; 167(2):174-81. PubMed ID: 17242319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of outcome from cardiovascular disease.
    Khuseyinova N; Koenig W
    Curr Opin Crit Care; 2006 Oct; 12(5):412-9. PubMed ID: 16943718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment in the patient with established peripheral arterial disease.
    Haugen S; Casserly IP; Regensteiner JG; Hiatt WR
    Vasc Med; 2007 Nov; 12(4):343-50. PubMed ID: 18048472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
    Corrado E; Rizzo M; Muratori I; Coppola G; Novo S
    Menopause; 2008; 15(2):240-7. PubMed ID: 17917609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.